1. Polyzos SA, Kountouras J, Shields K, Mantzoros CS. Irisin: A renaissance in metabolism. Metabolism. 2013;62(8):1037-44.
2. Pedersen BK. A muscular twist on the fate of fat. New Engl J Med. 2012; 366(16): 1544-5.
3. Pedersen BK. Muscles and their myokines. Exp Biol. 2011;214(2): 337–46.
4. Ellingsgaard H, Hauselmann I, Schuler B. Interleukin-6 enhances insulin secretion by increasing glucagon-like peptide-1 secretion from L cells and alpha cells. Nat Med. 2011; 17: 1481–89.
5. Pedersen BK, Febbraio MA. Muscle as an endocrine organ: Focus on muscle-derived interleukin-6. Physiol Rev. 2008; 88(4): 1379–406.
6. Kishore U, Reid K B M. C1q: structure, function, and receptors. Immunopharm. 2000; 49(2):159–70.
7. Seldin MM, Peterson JM, Byerly MS, Wei Z, Wong GW. Myonectin (CTRP15): A novel myokine that links skeletal muscle to systemic lipid homeostasis. Biol Chem. 2012; 287:11968–80.
8. Seldin MM, Wong GW. Regulation of tissue crosstalk by skeletal muscle-derived myonectin and other myokines. Adipocyte. 2012;1(4): 200-2.
9. Peterson JM, Mart R, Bond CE. Effect of obesity and exercise on the expression of the novel myokines, myonectin and fibronectin type III domain containing 5, Peer. 2014;2: 31-52.
10. Lim S, Choi SH, Koo BK, Kang SM, Yoon JW, Jang HC, et al. Effects of aerobic exercise training on C1q tumor necrosis factor related protein isoform 5 (myonectin): Association with insulin resistance and mitochondrial DNA density in women. J Clin Endocrinol Metab. 2012; 97(1):88-93.
11. Bonen A, Chabowski A, Luiken JJFP, Glatz JFC. Mechanisms and regulation of protein-mediated cellular fatty acid uptake: Molecular, biochemical, and physiological evidence. Physiology. 2007; 22:15-28.
12. Jain SS, Chabowski A, Snook LA, Schwenk RW, Glatz JFC, Luiken JFFP, et al. Additive effects of insulin and muscle contraction on fatty acid transport and fatty acid transporters, FAT/CD36, FABPpm, FATP1, 4 and 6. FEBS. 2009;(583): 2294–300.
13. Gamas L. Matafome P. Seiça R. Irisin and myonectin regulation in the insulin resistant muscle: Implications to adipose tissue: Muscle Crosstalk. Diabetes Res. 2015; 8(15):1-8.
14. Bing RJA, Siegel A, Ungar I, Gulbert M. Metabolism of the human heart. Am J Med. 1954; 16: 504-15.
15. Van der Vusse GJJF, Glatz HC. Stam HC, and Reneman RS. Fatty acid homeostasis in the normoxic and ischemic heart. Physiol Rev. 1992; 72: 881–940.
16. Bonen A, Chabowski A, Luiken JJFP. Glatz JFC. Is membrane transport of FFA mediated by lipid, protein, or both? Mechanisms and regulation of protein-mediated cellular fatty acid uptake: Molecular, biochemical, and physiological evidence (Invited review). Physiology (Bethesda). 2007; 22: 15–29.
17. Bayati M, Gharakhanlou R, Farzad B. Adaptations of physiological performance following high-intensity interval training. JEP. 2015;7(26): 15-32. (In Persian).
18. MacDougall JD, Hicks AL, MacDonald JR, McKelvie RS, Green HJ, Smith KM. Muscle performance and enzymatic adaptations to sprint interval training. J Appl Physiol. 1998; 84: 2138–42.
19. Ross A, Leveritt M. Long-term metabolic and skeletal muscle adaptations to short-sprint training: implications for sprint training and tapering. Sports Med. 2001; 15: 1063–82.
20. Seldin MM, Lei X, Tan SY, Stanson KP, Wei Z, Wong GW. Skeletal muscle-derived myonectin activates the mammalian target of rapamycin (mTOR) pathway to suppress autophagy in liver. Biol chem. 2013; 288(50): 36073–82.
21. Daisuke H, Yuko Y, Kitaoka Y, Hideo H, Arend B. High-intensity interval training increases intrinsic rates of mitochondrial fatty acid oxidation in rat red and white skeletal muscle. App Physiol Nut Metab. 2013; 38(3): 61-9.